Protocatechuic acid (PCA), also known as 3,4-dihydroxybenzoic acid, is a phenolic acid substance naturally present in many vegetables and fruits, and is also a key component of many traditional Chinese medicines (such as Danshen and Hibiscus). Effective active ingredients. Protocatechuic acid is a water-soluble phenolic acid component and an active substance in many traditional Chinese medicines. It not only has the effects of anti-platelet aggregation, reducing myocardial oxygen consumption, improving myocardial oxygen tolerance, slowing heart rate, antibacterial, analgesia, etc. Pharmacological activity, and also has antioxidant, anti-tumor and neuroprotective effects.
Protocatechuic acid (PA) is widely found in commonly used Chinese herbal medicines such as Acanthopanax sessilifolia, Herba Orientalis, and Herba Glehniae. It is a water-soluble phenolic acid component that not only significantly reduces myocardial oxygen consumption, but also improves It has pharmacological effects such as myocardial oxygen tolerance and slowing heart rate, and also has obvious anti-HBV effects[1].
Alias: 3,4-dihydroxybenzoic acid
Pharmacological effects: This product has antibacterial effects. In vitro tests show different degrees of antibacterial effects on Pseudomonas aeruginosa, Escherichia coli, Salmonella typhi, Shigella dysenteriae, Alcaligenes, Bacillus subtilis and Staphylococcus aureus. It also has expectorant and antiasthmatic effects. It is clinically used to treat chronic tracheitis.
Shelf life: 2 years
Storage: Store in a cool, dry, dark environment
Protocatechuic acid (PCA) has multiple pharmacological activities such as antiplatelet aggregation, reducing myocardial oxygen consumption, antibacterial, and analgesia. It is an important natural active substance. Recent studies have found many new pharmacological effects of PCA, such as antioxidant, anticancer, and mediating tumor cell apoptosis.
1. Antibacterial effect
Protocatechuic acid has inhibitory effects on Staphylococcus aureus and Staphylococcus aureus, Pneumococcus, Streptococcus A, Haemophilus influenzae, Pseudomonas aeruginosa, Escherichia coli, and Proteus. Staphylococcus aureus infection in mice can reduce mortality by 30%.
2. Effects on the cardiovascular system
(1) Effects on coronary vessels and myocardial oxygen consumption
